التفاصيل البيبلوغرافية
| العنوان: |
Individualized homeopathic medicines and Urtica urens mother tincture in treatment of hyperuricemia: an open, randomized, pragmatic, pilot trial. |
| المؤلفون: |
Nayak, Chintamani, Pattanaik, Nivedita, Chattopadhyay, Abhijit, Misra, Pankhuri, Bhar, Koushik, Michael, James, Koley, Munmun, Saha, Subhranil |
| المصدر: |
Journal of Complementary & Integrative Medicine; Sep2021, Vol. 18 Issue 3, p599-608, 10p |
| مصطلحات موضوعية: |
THERAPEUTIC use of plant extracts, HYPERURICEMIA, STINGING nettle, PILOT projects, INDIVIDUALIZED medicine, HOMEOPATHIC agents, URICOSURIC agents, TREATMENT effectiveness, RANDOMIZED controlled trials, PRE-tests & post-tests, COMPARATIVE studies, T-test (Statistics), HEALTH behavior, QUESTIONNAIRES, DESCRIPTIVE statistics, COMBINED modality therapy, URIC acid, BEHAVIOR modification, EVALUATION |
| مصطلحات جغرافية: |
INDIA |
| مستخلص: |
The quality of management of hyperuricemia has remained sub-optimal owing to unavoidable toxicities, limitations, and dearth of novel advances. Homeopathy has remained under-researched in hyperuricemia. We investigated the clinical effectiveness of three treatment regimens – individualized homeopathy (IH), Urtica urens mother tincture (UUMT), and both (IH + UUMT) along with lifestyle modifications in a sample of 90 patients with hyperuricemia. An open, randomized (1:1:1), 3 parallel arms (IH, UUMT, and IH + UUMT), pragmatic trial was conducted at National Institute of Homoeopathy, Kolkata. Outcome measures were serum uric acid (primary), Gout Assessment Questionnaire version 2 (GAQ2, secondary), and Measure Yourself Medical Outcome Profile version 2 (MYMOP2, secondary); all measured at baseline, and after 3 and 6 months. Intention- to-treat sample was analyzed to detect group differences by unpaired t tests. Attrition rate was 8.9% (IH: 3, UUMT: 3, IH + UUMT: 2). Groups were comparable at baseline. Reductions in serum uric acid over 3 months were comparatively higher (p=0.057) in the UUMT group than others, however, the differences were narrowed over 6 months (p=0.119). Per protocol analysis of serum uric acid level revealed similar trend of significantly higher reduction in the UUMT group than the other two (3 months: p=0.001; 6 months: p=0.007). No significant differences existed in reductions of GAQ2 scores among the three groups. Few significant differences were detected in MYMOP scores over 3 months favoring IH against others (symptom 2, p=0.001 and wellbeing score, p=0.002), and also over 6 months favoring IH + UUMT against others (symptom 1, p<0.001). Although all three therapies showed similar improvements, the IH + UUMT group had more positive direction of effects than IH or UUMT alone; however, no definite conclusion could be arrived at. Further trials are warranted with larger sample size. Trial registration: CTRI/2018/05/014026. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Complementary & Integrative Medicine is the property of De Gruyter and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
